Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Global PARP Inhibitor Market: Size, Trends and Forecasts 2016-2020 Featuring AstraZeneca, AbbVie, Clovis Oncology, Medivation, & Tesaro - Research and Markets

Research and Markets
Posted on: 14 Nov 16

Research and Markets has announced the addition of the "Global PARP Inhibitor Market: Size, Trends and Forecasts (2016-2020)" report to their offering.

Global PARP Inhibitor Market: Size, Trends and Forecasts (2016-2020) provides an in-depth analysis of the global PARP inhibitor market with detailed analysis of market size on the basis of value along with the comprehensive examination of each of the segments of the market, namely, Lynparza, Niraparib, Rucaparib, Talazoparib and Veliparib.

The report analyses the global Lynparza market in detail along with the regional analysis as it is the only commercialized product in the market. The clinical trials of Niraparib, Rucaparib, Talazoparib and Veliparib are also summarized along with the anticipated market commencement for each of the products.

The report provides detailed market potential of PARP inhibitor in Ovarian cancer, Breast cancer, Prostate cancer and Pancreatic cancer. This section provides the detailed analysis of the clinical trials of various PARP inhibitors for the concerned cancer treatment.

The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global PARP inhibitor market has also been forecasted for the period 2016-2020, taking into consideration the research & development, the growth drivers and the current and future trends. The competition in the global PARP inhibitor market is stiff and dominated by the big players like AstraZeneca. Further, key players in the market, AbbVie, Clovis Oncology, Medivation and Tesaro are also profiled with their financial information and respective business strategies.

Company Coverage

- AstraZeneca PLC

- AbbVie Inc.

- Clovis Oncology, Inc.

- Medivation, Inc.

- Tesaro, Inc.

Key Topics Covered:

1. Executive Summary

2. Introduction

3. Global Market Analysis

4. Global PARP Inhibitor Market Potential Analysis

5. Market Dynamics

6. Competitive Landscape

7. Company Profiling

For more information about this report visit http://www.researchandmarkets.com/research/2bm4c8/global_parp

View source version on businesswire.com: http://www.businesswire.com/news/home/20161114005952/en/

Business Wire
www.businesswire.com

Last updated on: 14/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.